SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-003357
Filing Date
2024-02-07
Accepted
2024-02-07 16:06:21
Documents
18
Period of Report
2024-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240205_8k.htm   iXBRL 8-K 40793
2 EXHIBIT 99.1 ex_623386.htm EX-99.1 18062
3 EXHIBIT 99.2 ex_622961.htm EX-99.2 6243
8 logosmall.jpg GRAPHIC 6556
  Complete submission text file 0001437749-24-003357.txt   219304

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240205.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240205_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240205_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240205_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240205_8k_htm.xml XML 2820
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24604304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)